BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6502758)

  • 1. Effect of GM1 ganglioside treatment on postlesion responses of cholinergic enzymes in rat hippocampus after various partial deafferentations.
    Oderfeld-Nowak B; Skup M; Ułas J; Jezierska M; Gradkowska M; Zaremba M
    J Neurosci Res; 1984; 12(2-3):409-20. PubMed ID: 6502758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside-induced alterations in hippocampal cholinergic enzymes and Na,K-ATPase after fimbria-fornix transection.
    Fass B; Ramirez JJ; Stein DG; Mahadik SP; Karpiak SE
    J Neurosci Res; 1987; 17(1):45-50. PubMed ID: 3033257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the time course of GM1 ganglioside effect on changes in choline acetyltransferase activity in partially denervated rat hippocampus.
    Skup M; Gradkowska M; Ułas J; Oderfeld-Nowak B
    Acta Neurobiol Exp (Wars); 1987; 47(5-6):199-211. PubMed ID: 3445796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP; Mukherjee S
    Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesions.
    Wójcik M; Ułas J; Oderfeld-Nowak B
    Neuroscience; 1982 Feb; 7(2):495-9. PubMed ID: 7078734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
    Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
    J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of GM1 ganglioside on cholinergic and serotoninergic systems in the rat hippocampus following partial denervation is dependent on the degree of fiber degeneration.
    Gradkowska M; Skup M; Kiedrowski L; Calzolari S; Oderfeld-Nowak B
    Brain Res; 1986 Jun; 375(2):417-22. PubMed ID: 3730833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS.
    Fass B; Ramirez JJ
    J Neurosci Res; 1984; 12(2-3):445-58. PubMed ID: 6502760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality.
    Mahadik SP; Vilim F; Korenovsky A; Karpiak SE
    J Neurosci Res; 1988 Aug; 20(4):479-83. PubMed ID: 3184210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1.
    Garofalo L; Ribeiro-da-Silva A; Cuello AC
    Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in ornithine decarboxylase activity in a partially denervated hippocampus of rats untreated and treated with GM1 ganglioside.
    Skup M; Gradkowska M
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):523-32. PubMed ID: 2130667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects.
    Maysinger D; Jalsenjak V; Stolnik S; Garofalo L; Cuello AC; Jalsenjak I
    J Microencapsul; 1989; 6(1):35-42. PubMed ID: 2715912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM1 ganglioside facilitates the recovery of high-affinity choline uptake in the cerebral cortex of rats with a lesion of the nucleus basalis magnocellularis.
    Pedata F; Giovannelli L; Pepeu G
    J Neurosci Res; 1984; 12(2-3):421-7. PubMed ID: 6502759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of cerebral edema with GM1 ganglioside.
    Karpiak SE; Mahadik SP
    J Neurosci Res; 1984; 12(2-3):485-92. PubMed ID: 6094838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can functional reorganization of area 17 following monocular deprivation be modified by GM1 internal ester treatment?
    Carmignoto G; Canella R; Bisti S
    J Neurosci Res; 1984; 12(2-3):477-83. PubMed ID: 6502761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.
    Kojima H; Gorio A; Janigro D; Jonsson G
    Neuroscience; 1984 Dec; 13(4):1011-22. PubMed ID: 6441897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1.
    Cuello AC; Stephens PH; Tagari PC; Sofroniew MV; Pearson RC
    Brain Res; 1986 Jun; 376(2):373-7. PubMed ID: 3730841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Luthman J; Zanoni R
    J Neurosci Res; 1984; 12(2-3):459-75. PubMed ID: 6438349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.